Maude Device Alert Short
In plain terms
The original device-report strategy remains inactive; its historical publication series is incomplete.
How it works
Legacy safety-report stress hypothesis; complete public-release history and device-maker attribution are unproven. No measured device equity return effect is established.
Data dependencies
- Daily prices
Adjusted-close OHLCV for every US-listed ticker; primary price feed.
- Fda maude device severity daily
A data feed this strategy reads, refreshed on its normal schedule.
Expected edge
- Tested over
- T+1 to T+40d
See the source research for the original effect size; a modern replication on new data may be weaker.
Example tickers where this is likely to fire
Illustrative only, the signal fires based on the live data, not a fixed list.
Related families
Pharma stocks drop after a spike in serious side-effect reports for a marketed drug. Short the day after the 7-day rolling severity z-score crosses +2.
When a carmaker has an unusually large recall wave, we short the stock for the next few weeks.
Explore Maude Device Alert Short on alphactor.ai
See which tickers this family is currently firing on, with live signals and rankings.